MedPath

Comparison of success rates between two devices called AIR Q and LMA Blockbuster which are used to pass a tube into the wind pipe and secure the airway as well as ensure normal breathing in patients taken for surgery and undergoing general anesthesia

Recruiting
Conditions
Other Procedures,
Registration Number
CTRI/2019/10/021623
Lead Sponsor
All India Institute of Medical Sciences
Brief Summary

**This study is a randomized controlled parallel group study comparing the success rates of blind intubation using AIR-Q and LMA Blockbuster. Both are intubating supraglottic devices but to the best of our knowledge success rates of the two havent been compared.**

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
140
Inclusion Criteria

ASA I& II Patients undergoing elective surgery under general anaesthesia requiring tracheal intubation Weight < 90kg, BMI < 30kg/m2.

Exclusion Criteria
  • •Patient refusal to participate in the study.
  • •Respiratory or pharyngeal pathology.
  • •Patients with cervical spine disease.
  • •Potential difficult airway •Risk of regurgitation.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of attempts to successful intubation through SGA.Time for placement of sga | Time for intubation through sga | Time for SGA removal | Vitals(HR, NIBP, SPO2, eTCO2) at baseline,2mins,4mins,6mins, 8mins,10mins,15mins,25mins, 35mins,45mins, 55mins,65mins,75mins,85mins,95mins,105mins,115mins,125mins.
Secondary Outcome Measures
NameTimeMethod
Number of attempts to successful placement of SGAInsertion time of the study device

Trial Locations

Locations (1)

All India Institute of Medical Sciences

🇮🇳

Delhi, DELHI, India

All India Institute of Medical Sciences
🇮🇳Delhi, DELHI, India
Kavitha Girish
Principal investigator
9500817025
kavithagirish94@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.